Redmile Group
Venture Capital
Healthcare-focused hedge fund and crossover investor backing biotech, therapeutics, and life sciences companies from early stage to public markets.
Seed
Early Stage
Growth
Late Stage
Biotech
Healthcare
Life Sciences
Therapeutics
- Headquarters
- San Francisco, United States
- Founded
- 2007
- Website
- redmilegroup.com
- AUM
- $1.4B
- Last Investment
- Feb 2025
- Geographic Focus
- United States
Investment Thesis
Healthcare-specialist crossover fund investing across the continuum from early venture to public biotech and life sciences companies.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account